O

Serial Number 86802253
606

Registration Progress

Application Filed
Oct 28, 2015
Under Examination
Apr 26, 2016
Approved for Publication
Mar 1, 2016
Published for Opposition
Mar 1, 2016
Registered

Trademark Image

O

Basic Information

Serial Number
86802253
Filing Date
October 28, 2015
Published for Opposition
March 1, 2016
Abandonment Date
May 27, 2019
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 27, 2019
Classes
005

Rights Holder

Argos Therapeutics, Inc.

03
Address
4233 Technology Drive
Durham, NC 27704

Ownership History

Argos Therapeutics, Inc.

Original Applicant
03
Durham, NC

Argos Therapeutics, Inc.

Owner at Publication
03
Durham, NC

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

39 events
Date Code Type Description Documents
May 28, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 27, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 6, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 5, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 5, 2018 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 28, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 28, 2018 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 20, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 18, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 18, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Apr 18, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 12, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 10, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 10, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 10, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 18, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 14, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 14, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 14, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 25, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 23, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 23, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 23, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 26, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 1, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 1, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 10, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 27, 2016 ALIE A ASSIGNED TO LIE Loading...
Jan 27, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jan 19, 2016 ALIE A ASSIGNED TO LIE Loading...
Nov 18, 2015 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 18, 2015 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Nov 18, 2015 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 18, 2015 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 18, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 13, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 3, 2015 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 2, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 31, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer, infectious disease, and the treatment or prevention of unwanted immune responses
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a stylized letter "O" with the leading edge bisected by a dot and triangle.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ARGOS

Classification

International Classes
005